| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/2004 | EP1380296A1 Hsp inductor |
| 01/14/2004 | EP1380295A1 Photosensitiser and method for production thereof |
| 01/14/2004 | EP1380290A1 Cross-beta structure pathway and its therapeutic relevance |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379694A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 01/14/2004 | EP1379689A2 Oligonucleotide conjugates |
| 01/14/2004 | EP1379679A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379661A2 Regulation of human gnat acetyltransferase-like protein |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379624A2 Transfection of human embryonic stem cells |
| 01/14/2004 | EP1379557A2 Use of cd25 binding molecules in steroid-resistant patients |
| 01/14/2004 | EP1379542A2 Treatment of tumours |
| 01/14/2004 | EP1379533A2 Novel cyclo azaphospha hydrocarbons |
| 01/14/2004 | EP1379528A1 Pyrazolopyrimidines as therapeutic agents |
| 01/14/2004 | EP1379524A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 01/14/2004 | EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379505A2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/14/2004 | EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 01/14/2004 | EP1379501A1 Indolinones, substituted in position 6, and their use as kinase inhibitors |
| 01/14/2004 | EP1379499A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379276A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379262A1 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 01/14/2004 | EP1379257A2 Prodrugs of anticancer agents employing substituted aromatic acids |
| 01/14/2004 | EP1379253A1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 01/14/2004 | EP1379251A1 Inhibitors of akt activity |
| 01/14/2004 | EP1379250A2 A method of treating cancer |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379243A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 01/14/2004 | EP1379242A1 Method for treatment of cancer and compositions for use therein |
| 01/14/2004 | EP1379241A1 Compounds and methods |
| 01/14/2004 | EP1379240A1 Compounds and methods |
| 01/14/2004 | EP1379238A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| 01/14/2004 | EP1379231A2 Pharmacologically active strong acid solutions |
| 01/14/2004 | EP1379229A2 A jasmonate pharmaceutical composition for treatment of cancer |
| 01/14/2004 | EP1379228A1 (z)-styrylbenzylsulfones and pharmaceutical uses thereof |
| 01/14/2004 | EP1379224A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/14/2004 | EP1272189A4 Inhibition of cyclooxygenase-2 activity |
| 01/14/2004 | EP1255745B1 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii |
| 01/14/2004 | EP1150683B9 Utilization of dienogest in high doses |
| 01/14/2004 | EP1095018B1 Aminoiminoquinone and aminoquinone alkaloid compounds as caspase inhibitors |
| 01/14/2004 | EP1019059A4 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468259A Immunotherapy for chronic myelocytic leukemia |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1468247A Ethers of 7-desmethylrapamycin |
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468243A Polymorphs of an epothilone analog |
| 01/14/2004 | CN1468240A Derivatives of variolin b |
| 01/14/2004 | CN1468231A Amorphous form of cell cycle inhibitor |
| 01/14/2004 | CN1468230A Chemical compounds |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468220A New piperidine derivatives |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1468124A Method and composition for altering a t cell mediated pathology |
| 01/14/2004 | CN1468123A Method and composition for altering a b cell mediated pathology |
| 01/14/2004 | CN1468103A Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 01/14/2004 | CN1468102A Modified prodrug forms of ap/amp |
| 01/14/2004 | CN1468099A Antitumor therapy comprising distamycin derivatives |
| 01/14/2004 | CN1467222A Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line |
| 01/14/2004 | CN1467219A Pentapeptide analog, preparation and uses thereof |
| 01/14/2004 | CN1467218A Application of misplaced dichain oligonucleotide in preparing medicines for treating human liver cancer |
| 01/14/2004 | CN1467210A 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses |
| 01/14/2004 | CN1466994A Compositions and therapeutic use |
| 01/14/2004 | CN1466991A Antimutagenic effects of ganoderma lucidum spores |
| 01/14/2004 | CN1466972A Effective component preparation of metapanax of araliaceae and method for preparing the same |
| 01/14/2004 | CN1466962A Method for processing aloe gelatin, aloe full-leaf gelatin and aloe skin gelatin |
| 01/14/2004 | CN1466960A Medicine for treating tumour and leucocythemia |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/14/2004 | CN1134450C LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| 01/14/2004 | CN1134444C Epothilone analog and medicine combination |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134439C Pyrrolo [2,3D] pyrimidines and their use as tyrosine kinase inhibitors |
| 01/14/2004 | CN1134438C Bicyclic heteroaromatic compounds, method for prepearing the same and uses |
| 01/14/2004 | CN1134433C Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 01/14/2004 | CN1134430C Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134405C 5,6-Dihydronaphthalenyl derivatives having retionoid-like activity |
| 01/14/2004 | CN1134255C Antineoplastic cocoa extracts, method for making and uses |
| 01/13/2004 | US6677453 Production of polymorphic forms I and II of finasteride by complexation with group I or II metal salts |
| 01/13/2004 | US6677450 N12, n13-bridged sugar derivatives of indolylopyrrolocarbazoles, useful in inhibiting the proliferation of tumor cells |
| 01/13/2004 | US6677435 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-michael catalytic activity; antitumor; anticarcinogenic agents |
| 01/13/2004 | US6677383 Hydroxylation activated prodrugs |